Drebrin Autoantibodies in Patients with Seizures and Suspected Encephalitis.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
06 2020
Historique:
received: 17 07 2019
revised: 11 03 2020
accepted: 12 03 2020
pubmed: 21 3 2020
medline: 21 10 2020
entrez: 21 3 2020
Statut: ppublish

Résumé

Assess occurrence of the dendritic spine scaffolding protein Drebrin as a pathophysiologically relevant autoantibody target in patients with recurrent seizures and suspected encephalitis as leading symptoms. Sera of 4 patients with adult onset epilepsy and suspected encephalitis of unresolved etiology and equivalent results in autoantibody screening were subjected to epitope identification. We combined a wide array of approaches, ranging from immunoblotting, immunoprecipitation, mass spectrometry, subcellular binding pattern analyses in primary neuronal cultures, and immunohistochemistry in brains of wild-type and Drebrin knockout mice to in vitro analyses of impaired synapse formation, morphology, and aberrant neuronal excitability by antibody exposure. In the serum of a patient with adult onset epilepsy and suspected encephalitis, a strong signal at ∼70kDa was detected by immunoblotting, for which mass spectrometry revealed Drebrin as the putative antigen. Three other patients whose sera also showed strong immunoreactivity around 70kDa on Western blotting were also anti-Drebrin-positive. Seizures, memory impairment, and increased protein content in cerebrospinal fluid occurred in anti-Drebrin-seropositive patients. Alterations in cerebral magnetic resonance imaging comprised amygdalohippocampal T2-signal increase and hippocampal sclerosis. Diagnostic biopsy revealed T-lymphocytic encephalitis in an anti-Drebrin-seropositive patient. Exposure of primary hippocampal neurons to anti-Drebrin autoantibodies resulted in aberrant synapse composition and Drebrin distribution as well as increased spike rates and the emergence of burst discharges reflecting network hyperexcitability. Anti-Drebrin autoantibodies define a chronic syndrome of recurrent seizures and neuropsychiatric impairment as well as inflammation of limbic and occasionally cortical structures. Immunosuppressant therapies should be considered in this disorder. ANN NEUROL 2020;87:869-884.

Identifiants

pubmed: 32196746
doi: 10.1002/ana.25720
doi:

Substances chimiques

Autoantibodies 0
Epitopes 0
Neuropeptides 0
drebrins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

869-884

Informations de copyright

© 2020 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association.

Références

Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci 2015;1338:94-114.
Vincent A, Bien CG, Irani SR, Waters P. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011;10:759-772.
Soeder BM, Gleissner U, Urbach H, et al. Causes, presentation and outcome of lesional adult onset mediotemporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2009;80:894-899.
Irani SR, Bien CG, Lang B. Autoimmune epilepsies. Curr Opin Neurol 2011;24:146-153.
Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011;69:892-900.
Saiz A, Blanco Y, Sabater L, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008;131:2553-2563.
Heine J, Pruss H, Bartsch T, et al. Imaging of autoimmune encephalitis-relevance for clinical practice and hippocampal function. Neuroscience 2015;309:68-83.
Bauer J, Bien CG. Neuropathology of autoimmune encephalitides. Handb Clin Neurol 2016;133:107-120.
Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-1140.
Brenner T, Sills GJ, Hart Y, et al. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 2013;54:1028-1035.
Gable MS, Gavali S, Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009;28:1421-1429.
Malter MP, Helmstaedter C, Urbach H, et al. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010;67:470-478.
Boronat A, Gelfand JM, Gresa-Arribas N, et al. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol 2013;73:120-128.
Shirao T, Obata K. Two acidic proteins associated with brain development in chick embryo. J Neurochem 1985;44:1210-1216.
Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341-355.
Fischl B, Salat DH, van der Kouwe AJ, et al. Sequence-independent segmentation of magnetic resonance images. Neuroimage 2004;23:S69-S84.
Alvarez-Baron E, Bien CG, Schramm J, et al. Autoantibodies to Munc18, cerebral plasma cells and B-lymphocytes in Rasmussen encephalitis. Epilepsy Res 2008;80:93-97.
Blumcke I, Spreafico R, Haaker G, et al. Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med 2017;377:1648-1656.
Evans GJ. Subcellular fractionation of the brain: preparation of synaptosomes and synaptic vesicles. Cold Spring Harb Protoc 2015;2015:462-466.
Scharf M, Miske R, Kade S, et al. A spectrum of neural autoantigens, newly identified by histo-immunoprecipitation, mass spectrometry, and recombinant cell-based indirect immunofluorescence. Front Immunol 2018;9:1447.
Geraldo S, Khanzada UK, Parsons M, et al. Targeting of the F-actin-binding protein Drebrin by the microtubule plus-tip protein EB3 is required for neuritogenesis. Nat Cell Biol 2008;10:1181-1189.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
van Loo KMJ, Rummel CK, Pitsch J, et al. Calcium channel subunit α2δ4 is regulated by early growth response 1 and facilitates epileptogenesis. J Neurosci 2019;39:3175-3187.
Jung G, Kim EJ, Cicvaric A, et al. Drebrin depletion alters neurotransmitter receptor levels in protein complexes, dendritic spine morphogenesis and memory-related synaptic plasticity in the mouse hippocampus. J Neurochem 2015;134:327-339.
Pitsch J, Schoch S, Gueler N, et al. Functional role of mGluR1 and mGluR4 in pilocarpine-induced temporal lobe epilepsy. Neurobiol Dis 2007;26:623-633.
Kreis P, Hendricusdottir R, Kay L, et al. Phosphorylation of the actin binding protein Drebrin at S647 is regulated by neuronal activity and PTEN. PLoS One 2013;8:e71957.
Shirao T, Hanamura K, Koganezawa N, et al. The role of Drebrin in neurons. J Neurochem 2017;141:819-834.
Reiber H. External quality assessment in clinical neurochemistry: survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF/serum quotients. Clin Chem 1995;41:256-263.
Hansen N, Widman G, Witt JA, et al. Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis. Epilepsy Behav 2016;65:18-24.
Pellkofer H, Schubart AS, Hoftberger R, et al. Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat. Brain 2004;127:1822-1830.
Werner C, Pauli M, Doose S, et al. Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition. Brain 2016;139:365-379.
Poh MQ, Simon NG, Buckland ME, et al. Evidence of T-cell mediated neuronal injury in stiff-person syndrome with anti-amphiphysin antibodies. J Neurol Sci 2014;337:235-237.
Counts SE, Nadeem M, Lad SP, et al. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J Neuropathol Exp Neurol 2006;65:592-601.
Shim KS, Lubec G. Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome. Neurosci Lett 2002;324:209-212.
Counts SE, He B, Nadeem M, et al. Hippocampal Drebrin loss in mild cognitive impairment. Neurodegener Dis 2012;10:216-219.
Lacor PN, Buniel MC, Furlow PW, et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 2007;27:796-807.
Mahadomrongkul V, Huerta PT, Shirao T, Aoki C. Stability of the distribution of spines containing Drebrin A in the sensory cortex layer I of mice expressing mutated APP and PS1 genes. Brain Res 2005;1064:66-74.
Ferhat L. Potential role of Drebrin A, an F-actin binding protein, in reactive synaptic plasticity after pilocarpine-induced seizures: functional implications in epilepsy. Int J Cell Biol 2012;2012:474351.

Auteurs

Julika Pitsch (J)

Section for Translational Epilepsy Research, Department of Neuropathology, University Hospital Bonn, Bonn, Germany.

Delara Kamalizade (D)

Section for Translational Epilepsy Research, Department of Neuropathology, University Hospital Bonn, Bonn, Germany.

Anna Braun (A)

Section for Translational Epilepsy Research, Department of Neuropathology, University Hospital Bonn, Bonn, Germany.

Julia C Kuehn (JC)

Section for Translational Epilepsy Research, Department of Neuropathology, University Hospital Bonn, Bonn, Germany.

Polina E Gulakova (PE)

Section for Translational Epilepsy Research, Department of Neuropathology, University Hospital Bonn, Bonn, Germany.

Theodor Rüber (T)

Department of Epileptology, University Hospital Bonn, Bonn, Germany.
Center for Rare Diseases Bonn, University Hospital Bonn, Bonn, Germany.

Gert Lubec (G)

Paracelsus Medical University, Salzburg, Austria.

Dirk Dietrich (D)

Clinic for Neurosurgery, University Hospital Bonn, Bonn, Germany.

Randi von Wrede (R)

Department of Epileptology, University Hospital Bonn, Bonn, Germany.
Center for Rare Diseases Bonn, University Hospital Bonn, Bonn, Germany.

Christoph Helmstaedter (C)

Department of Epileptology, University Hospital Bonn, Bonn, Germany.
Center for Rare Diseases Bonn, University Hospital Bonn, Bonn, Germany.

Rainer Surges (R)

Department of Epileptology, University Hospital Bonn, Bonn, Germany.
Center for Rare Diseases Bonn, University Hospital Bonn, Bonn, Germany.

Christian E Elger (CE)

Department of Epileptology, University Hospital Bonn, Bonn, Germany.
Center for Rare Diseases Bonn, University Hospital Bonn, Bonn, Germany.

Elke Hattingen (E)

Department of Neuroradiology, University Clinic of Frankfurt, Frankfurt, Germany.

Hartmut Vatter (H)

Clinic for Neurosurgery, University Hospital Bonn, Bonn, Germany.

Susanne Schoch (S)

Section for Translational Epilepsy Research, Department of Neuropathology, University Hospital Bonn, Bonn, Germany.
Department of Epileptology, University Hospital Bonn, Bonn, Germany.

Albert J Becker (AJ)

Section for Translational Epilepsy Research, Department of Neuropathology, University Hospital Bonn, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH